SCHEMBL8180533

SCHEMBL8180533

O=C1NC(=O)C(=CC=Cc2cc3ccccc3s2)S1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.71
▸ CYP2A6 P11509 1/20 0.45
▸ PIM1 P11309 2/20 0.43
▸ PIM2 Q9P1W9 2/20 0.43
▸ PIM3 Q86V86 1/20 0.43
▸ TTR P02766 2/20 0.43
▸ AKR1B1 P15121 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ MGAM O43451 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ SI P14410 1/20 0.39
▸ MGAM2 Q2M2H8 1/20 0.39
▸ NR1H4 Q96RI1 1/20 0.39
▸ NAT1 P18440 1/20 0.39
▸ IGF1R P08069 1/20 0.39
▸ ALOX15 P16050 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ TUBB4A P04350 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8182711 0.95 GSK3B (0.68) GSK3BCYP2A6PIM1PIM2PIM3
SCHEMBL8182708 0.95 GSK3B (0.68) GSK3BCYP2A6PIM1PIM2PIM3
SCHEMBL8167446 0.87 GSK3B (0.54) GSK3BCYP2A6PIM1MEN1KMT2A
SCHEMBL8187128 0.77 PIM1 (0.53) GSK3BPIM1PIM2PIM3TTR
SCHEMBL22409598 0.76 AKR1B1 (0.51) GSK3BPIM1PIM2PIM3TTR
SCHEMBL22423776 0.76 AKR1B1 (0.51) GSK3BPIM1PIM2PIM3TTR
SCHEMBL13846678 0.74 PIM1 (0.67) GSK3BPIM1PIM2PIM3AKR1B1
SCHEMBL22423780 0.74 PIM1 (0.67) GSK3BPIM1PIM2PIM3AKR1B1
SCHEMBL22409611 0.74 PIM1 (0.67) GSK3BPIM1PIM2PIM3AKR1B1
SCHEMBL8183740 0.73 PIM1 (0.55) GSK3BCYP2A6PIM1PIM2PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018746-A1 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 — — WO disclosed
Send feedback